The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...

Evolutionary biology in particular is not new to political controversies. Over the past century, it has been at the center of several high-profile legal battles. Most famous are the debates about the ...

The perceived failure of current drug discovery has generated widespread concern, and several divergent opinions about the problem and its potential solutions. Horrobin 1 has gone so far as to liken ...

SOMERVILLE, Mass.--(BUSINESS WIRE)-- Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and develop protein therapeutics across ...

— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK--(BUSINESS ...